Many individuals and groups have voiced suggestions to manage our raging COVID-19 pandemic in Malaysia. However, few appear to have been considered. Dato’ Dr Amar-Singh HSS summarised five key measures critically needed to take to help put out the COVID-19 raging fire in our nation.
To counter the spread of misinformation and a lack of public awareness on vaccinations, The Petri Dish launched a campaign named TrustTheShot which seeks to collate credible and science-based information on vaccines and disseminate this information to the public.
“Doc, I don’t trust the Covid-19 vaccine because it’s too rushed. Normally, vaccines take 7-10 years to research.” Dr Khor SK in his opinion piece reassures that the Covid-19 vaccine is as safe as possible, with only one year of effective and accelerated research.
Following reports of a new strain of the coronavirus that is more infectious circulating in parts of the UK, British Health Secretary Matt Hancock on Sunday (20 Dec) said that the government has imposed a strict Christmas lockdown in London and southeast England.
Malaysia is expected to receive the first batch of the COVID-19 vaccine jointly developed by Pfizer and BioNTech in February next year. This fact sheet contains information to help you understand the risks and benefits of the Pfizer-BioNTech COVID-19 Vaccine.
While serious illness and deaths due to COVID-19 is uncommon among children, when the outbreak is very large, as occurring now, some children will sadly succumb. We need to be concerned for those children who are immunocompromised, malnourished, in poverty and have chronic disease.
The latest Sivagangga cluster from Kedah was suspected of being caused by a super spreader strain of the COVID-19 virus that originated from Egypt and Pakistan. Health authorities believed there is a high probability that the cluster is a super spreader because of its higher transmission rate compared to previous COVID-19 clusters. We spoke to Associate Prof. Dr Chan Yoke Fun, Virologist & Senior Lecturer at the Department of Medical Microbiology, Faculty of Medicine, University of Malaya to learn more.
These interim trial results show that hydroxychloroquine and lopinavir/ritonavir produce little or no reduction in the mortality of hospitalized COVID-19 patients when compared to standard of care. Solidarity trial investigators will interrupt the trials with immediate effect.
As of 12 May 2020, 4,425,094 people have been infected with SARS-CoV-2 with deaths reaching 297,723.Doctors are desperately looking for an effective drug, and there have been a number of candidates on trial; one of them, remdesivir, is probably the most exciting of all. This is the drug developed for the Ebola epidemic in 2015, but it was found to be less effective in clinical trials than in in vitro studies. Is remdesivir the panacea for COVID-19?
A research team at Oxford University has recently found a cheap and widely available drug called dexamethasone that can be used to effectively treat severe forms of COVID-19. The 'breakthrough' drug has shown to significantly reduce the number of deaths among those seriously ill with the coronavirus. We asked experts to comment on the effectiveness of the drug in treating COVID-19.